CPT 90756: Quadrivalent Cell-Derived Influenza Vaccine, 0.5 mL Intramuscular

CPT code 90756 denotes a cell culture–derived quadrivalent influenza vaccine administered as a 0.5 mL intramuscular injection. As a non-antibiotic, cell-based product covering four influenza strains, it is part of seasonal vaccination programs and clinical prevention efforts nationwide. The code is relevant for providers, payers, and public health stakeholders managing influenza immunization campaigns and billing workflows.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for this vaccine, typical sites of administration, and how the code is used in billing for outpatient and ambulatory immunization services. The publication also summarizes benchmarks and policy implications related to vaccine administration and reimbursement practices, and highlights common billing modifiers and operational considerations where data are available.

The content is intended to inform billing staff, practice managers, and payers about the clinical characterization of the product associated with CPT code 90756, the typical care settings for administration, and the elements that influence coding and claims processing at a national level.

Billing Code Overview

CPT code 90756 represents a quadrivalent influenza vaccine product formulated from cell cultures, free of antibiotics, and supplied as a 0.5 mL intramuscular injection. The vaccine protects against four strains of influenza and is intended for active immunization to prevent seasonal influenza infection.

Service type: Immunization (influenza vaccine)
Typical site of service: Outpatient clinic, primary care office, public health clinic, pharmacy-based vaccination site, or other ambulatory care settings where intramuscular vaccinations are provided.

Clinical Context

A 45-year-old adult presents to a primary care clinic during influenza season requesting routine immunization. The patient has no known egg allergy and reports no acute febrile illness. After screening for contraindications and documenting informed consent, a licensed nurse prepares the vaccine: a 0.5 mL intramuscular dose of a quadrivalent, cell-culture–derived influenza vaccine without antibiotics (90756). The typical workflow includes verification of eligibility and insurance, medical history and allergy check, vaccine counseling, informed consent, vaccine administration into the deltoid muscle, 15 minutes of observation for immediate adverse reactions, documentation in the electronic medical record and immunization registry, and billing using 90756 with any applicable modifier for payer reporting and provider circumstances.

Coding Specifications

Modifier	Description	When to Use
`00`	Service not modifier-specified	Rarely used; default when no other modifier applies
`11`	Professional component

Taxonomy Code	Specialty	Notes
`207Q00000X`	Family Medicine	Most common setting for adult influenza immunization
`208000000X`	Internal Medicine	Primary care internists commonly administer seasonal vaccines
`363L00000X`	Vaccination Provider	Clinicians with vaccine-focused practice or qualifications
`261QU0200X`	Nurse Practitioner	NPs frequently provide immunizations in clinics and retail settings
`367500000X`	Registered Nurse	Nurses administer the vaccine under clinician orders

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z23`	Encounter for immunization	Primary encounter code to indicate administration of routine influenza vaccine
`J00`	Acute nasopharyngitis [common cold]	Acute respiratory infection delayed vaccination until resolved; documents reason if vaccine deferred
`Z00.00`	Encounter for general adult medical examination without abnormal findings	Preventive visit during which influenza vaccine is commonly administered
`Z91.021`	Allergy to eggs	Relevant allergy code when vaccine contraindications or screening findings require documentation and possible alternative vaccine selection
`R50.9`	Fever, unspecified	If patient presents with fever, may defer vaccination; documents clinical decision-making

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`90471`	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); first or only component of each vaccine or toxoid administered	Used to bill the administration of a single vaccine dose when payer requires separate administration code in addition to vaccine product code
`90472`	Immunization administration; each additional vaccine/toxoid (single or combination vaccine/toxoid)	Used when multiple vaccines are administered during the same visit in addition to `90471`
`99401`	Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (15 minutes) — note: specific codes vary by payer	Used when a documented preventive counseling visit accompanies vaccination (use appropriate current CPT preventive codes as applicable)
`90756`	Quadrivalent, cell-culture derived influenza vaccine, intramuscular, 0.5 mL dose	The vaccine product itself; primary coded item for inventory and product reimbursement
`G0008`	Administration of influenza vaccine by qualified healthcare professional, Medicare-specific	Used for Medicare Part B reporting when billing for influenza vaccine administration (payer-specific reporting may use this instead of `90471`/`90472`)

OpenPayer

Summary & Overview